n | Crude % | RDS I % (95% CI) | RDS II % (95% CI) | RDS SS % (95% CI) | ||
---|---|---|---|---|---|---|
HIV-positive serostatus (vs. HIV-negative) | Overall | 199 | 27.7 | 22.5 (19.4–25.6) | 26.7 (20.7–32.7) | 26.7 (20.7–32.7) |
>0 Wave | 189 | 28.3 | 22.9 (19.7–26.2) | 27.7 (21.5–33.9) | 27.7 (21.4–34.1) | |
>1 Wave | 178 | 30.0 | 24.2 (20.6–27.7) | 29.3 (22.6–36.0) | 29.4 (22.6–36.1) | |
>2 Wave | 161 | 30.0 | 23.8 (20.1–27.5) | 29.1 (22.1–36.1) | 29.1 (22.1–36.2) | |
Any high risk sex in past 6 months (vs. none) | Overall | 262 | 37.3 | 34.9 (31.1–38.8) | 33.6 (27.6–39.6) | 33.7 (27.7–39.7) |
>0 Wave | 251 | 38.4 | 35.5 (31.5–39.5) | 35.2 (28.9–41.5) | 35.3 (29.0–41.6) | |
>1 Wave | 221 | 38.0 | 36.0 (31.7–40.3) | 35.8 (29.3–42.4) | 35.8 (29.2–42.4) | |
>2 Wave | 203 | 38.7 | 37.0 (32.4–41.5) | 36.4 (29.5–43.3) | 36.5 (29.6–43.3) | |
Injected any drugs in past 6 months (vs. none) | Overall | 61 | 7.1 | 8.8 (5.5–12.1) | 7.3 (3.9–10.7) | 7.3 (3.9–10.7) |
>0 Wave | 51 | 7.6 | 9.1 (5.8–12.4) | 8.1 (4.4–11.8) | 8.1 (4.3–11.9) | |
>1 Wave | 48 | 8.1 | 8.7 (5.7–11.7) | 8.0 (4.7–11.3) | 8.0 (4.7–11.3) | |
>2 Wave | 43 | 8.0 | 8.7 (5.5–11.9) | 8.3 (4.8–11.8) | 8.3 (4.8–11.9) |